bibliographicCitation |
Ienaga K, Yokozawa T. Treatment with NZ-419 (5-Hydroxy-1-methylimidazoline-2,4-dione), a Novel Intrinsic Antioxidant, against the Progression of Chronic Kidney Disease at Stages 3 and 4 in Rats. Biological & Pharmaceutical Bulletin. 2010;33(5):809–15. doi: 10.1248/bpb.33.809. |